Enzyme-linked immunosorbent assay characterization of basal variation and heritability of systemic microfibrillar-associated protein 4

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Sækmose, Susanne Gjørup ^a,b,c   Schlosser, Anders ^a   Holst, René ^a   Johansson, Sofie Lock ^a   Wulf Johansson, Helle ^a   Tornø, Ida ^a   Vestbo, Jørgen ^c,d   Kyvik, Kirsten Ohm ^a,c   Barington, Torben ^c   Holmskov, Uffe ^a   Sørensen, Grith Lykke ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b NAESTVED HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MICROFIBRILLAR ASSOCIATED PROTEIN 4; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALIBRATION; COHORT ANALYSIS; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HEREDITY; HERITABILITY; HUMAN; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PROCESS OPTIMIZATION; PROTEIN BLOOD LEVEL; SMOKING; TWINS; VALIDATION STUDY; WAIST HIP RATIO;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BIOLOGICAL MARKERS; CARRIER PROTEINS; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RECOMBINANT FUSION PROTEINS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SPECIES SPECIFICITY; TWINS; WAIST-HIP RATIO; YOUNG ADULT;

EID: 84891803982     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082383     Document Type: Article

References (26)

1. Zhao Z, Lee CC, Jiralerspong S, Juyal RC, Lu F et al. (1995) The gene for a human microfibril-associated glycoprotein is commonly deleted in Smith-Magenis syndrome patients. Hum Mol Genet 4: 589-597. doi: 10.1093/hmg/4.4.589. PubMed: 7633408.
2. Kobayashi R, Tashima Y, Masuda H, Shozawa T, Numata Y et al. (1989) Isolation and characterization of a new 36-kDa microfibril-associated glycoprotein from porcine aorta. J Biol Chem 264: 17437-17444. PubMed: 2793866.
3. Toyoshima T, Yamashita K, Furuichi H, Shishibori T, Itano T et al. (1999) Ultrastructural distribution of 36-kD microfibril-associated glycoprotein (MAGP-36) in human and bovine tissues. J Histochem Cytochem 47: 1049-1056. doi:10.1177/002215549904700809. PubMed: 10424889.
4. Toyoshima T, Ishida T, Nishi N, Kobayashi R, Nakamura T et al. (2008) Differential gene expression of 36-kDa microfibril-associated glycoprotein (MAGP-36/MFAP4) in rat organs. Cell Tissue Res 332: 271-278. doi:10.1007/s00441-008-0587-7. PubMed: 18322703.
5. Schlosser A, Thomsen T, Shipley JM, Hein PW, Brasch F et al. (2006) Microfibril-associated protein 4 binds to surfactant protein A (SP-A) and colocalizes with SP-A in the extracellular matrix of the lung. Scand J Immunol 64: 104-116. doi:10.1111/j.1365-3083.2006.01778.x. PubMed: 16867155.
6. Hirano E, Fujimoto N, Tajima S, Akiyama M, Ishibashi A et al. (2002) Expression of 36-kDa microfibril-associated glycoprotein (MAGP-36) in human keratinocytes and its localization in skin. J Dermatol Sci 28: 60-67. doi:10.1016/S0923-1811(01)00148-7. PubMed: 11916131.
7. Toyoshima T, Nishi N, Kusama H, Kobayashi R, Itano T (2005) 36-kDa microfibril-associated glycoprotein (MAGP-36) is an elastin-binding protein increased in chick aortae during development and growth. Exp Cell Res 307: 224-230. doi:10.1016/j.yexcr.2005.03.005. PubMed: 15922742.
8. Lausen M, Lynch N, Schlosser A, Tornoe I, Saekmose SG et al. (1999) Microfibril-associated protein 4 is present in lung washings and binds to the collagen region of lung surfactant protein D. J Biol Chem 274: 32234-32240. doi:10.1074/jbc.274.45.32234. PubMed: 10542261.
9. Kasamatsu S, Hachiya A, Fujimura T, Sriwiriyanont P, Haketa K et al. (2011) Essential role of microfibrillar-associated protein 4 in human cutaneous homeostasis and in its photoprotection. Sci Rep 1: 164. PubMed: 22355679.
10. Martinez-Hernandez A, Amenta PS (1993) The hepatic extracellular matrix. II. Ontogenesis, regeneration and cirrhosis. Virchows Arch A Pathol Anat Histopathol 423: 77-84. doi:10.1007/BF01606580. PubMed: 8212543.
11. Moller MJ, Qin Z, Toursarkissian B (2012) Tissue markers in human atherosclerotic carotid artery plaque. Ann Vasc Surg 26: 1160-1165. doi:10.1016/j.avsg.2012.06.008. PubMed: 23068427.
12. Roy R, Yang J, Moses MA (2009) Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 27: 5287-5297. doi:10.1200/JCO.2009.23.5556. PubMed: 19738110.
13. Lichtinghagen R, Michels D, Haberkorn CI, Arndt B, Bahr M et al. (2001) Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C. J Hepatol 34: 239-247. doi:10.1016/S0168- 8278(00)00037-4. PubMed: 11281552.
14. Mölleken C, Sitek B, Henkel C, Poschmann G, Sipos B et al. (2009) Detection of novel biomarkers of liver cirrhosis by proteomic analysis. Hepatology 49: 1257-1266. doi:10.1002/hep.22764. PubMed: 19177598.
15. DeLean A, Munson PJ, Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235: E97-102. PubMed: 686171.
16. Kyvik KO, Green A, Beck-Nielsen H (1995) The new Danish Twin Register: establishment and analysis of twinning rates. Int J Epidemiol 24: 589-596. doi:10.1093/ije/24.3.589. PubMed: 7672901.
17. Schousboe K, Visscher PM, Henriksen JE, Hopper JL, Sørensen TI et al. (2003) Twin study of genetic and environmental influences on glucose tolerance and indices of insulin sensitivity and secretion. Diabetologia 46: 1276-1283. doi:10.1007/s00125-003-1165-x. PubMed: 12898014.
18. Fisher RA (1918) The correlation between relatives on the supposition of mendelian inheritance. Trans R Soc Edinb 52: 399-433.
19. Rabe-Hesketh S, Skrondal A, Gjessing HK (2008) Biometrical modeling of twin and family data using standard mixed model software. Biometrics 64: 280-288. doi:10.1111/j.1541-0420.2007.00803.x. PubMed: 17484777.
20. Fenger M, Benyamin B, Schousboe K, Sørensen TI, Kyvik KO (2007) Variance decomposition of apolipoproteins and lipids in Danish twins. Atherosclerosis 191: 40-47. doi:10.1016/j.atherosclerosis.2006.04.024. PubMed: 16730014.
21. Sørensen GL, Hjelmborg JB, Kyvik KO, Fenger M, Høj A et al. (2006) Genetic and environmental influences of surfactant protein D serum levels. Am J Physiol Lung Cell Mol Physiol 290: L1010-L1017. doi: 10.1152/ajplung.00487.2005. PubMed: 16361352.
22. Canoy D (2010) Coronary heart disease and body fat distribution. Curr Atheroscler Rep 12: 125-133. doi:10.1007/s11883-010-0092-9. PubMed: 20425248.
23. Altamirano J, Bataller R (2010) Cigarette smoking and chronic liver diseases. Gut 59: 1159-1162. doi:10.1136/gut.2008.162453. PubMed: 20650922.
24. Yasue H, Hirai N, Mizuno Y, Harada E, Itoh T et al. (2006) Low-grade inflammation, thrombogenicity, and atherogenic lipid profile in cigarette smokers. Circ J 70: 8-13. doi:10.1253/circj.70.8. PubMed: 16377917.
25. Duarte-Rojo A, Altamirano JT, Feld JJ (2012) Noninvasive markers of fibrosis: key concepts for improving accuracy in daily clinical practice. Ann Hepatol 11: 426-439. PubMed: 22700624.
26. Boursier J, Vergniol J, Sawadogo A, Dakka T, Michalak S et al. (2009) The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis. Liver Int 29: 1507-1515. doi: 10.1111/j.1478-3231.2009.02101. x. PubMed: 19725892.